Article info

Download PDFPDF
Infliximab therapy downregulation of basic fibroblast growth factor/syndecan 1 link: a possible molecular pathway of mucosal healing in ulcerative colitis
  1. Correspondence to Professor Enzo Ierardi, Gastroenterology Section, Department of Medical Sciences, University of Foggia, AOU Ospedali Riuniti, Viale Pinto, 71100 Foggia, Italy; enzo.ierardi{at}fastwenet.it
View Full Text

Citation

Ierardi E, Giorgio F, Zotti M, et al
Infliximab therapy downregulation of basic fibroblast growth factor/syndecan 1 link: a possible molecular pathway of mucosal healing in ulcerative colitis

Publication history

  • Accepted May 22, 2011
  • First published September 22, 2011.
Online issue publication 
October 22, 2011

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.